COMP <GO>
HAE vs HTFL // EV/EBITDA & P/E VALUATION
Haemonetics Corporation (NYSE) VS. Heartflow Inc. (NASDAQ) • 15-METRIC TALLY: HAE 7
— HTFL 4
■ METRIC PARITY
LAST: $119.65 (-0.12%) • MKT CAP: $5.45B
valuation
32.5x
LAST: $59.05 (-2.44%) • MKT CAP: $5.26B
valuation
—
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (HAE VS. HTFL)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | HAE | HTFL | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 59.00% | 76.80% | -17.80 | HTFL | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 8.40% | -12.00% | +20.40 | HAE | /roic <GO> |
| EV/EBITDA & P/E Valuation ACTIVE | 32.5x | — | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | 4.78% | -1.12% | +5.90 | HAE | /fcf-yield <GO> |
| Operating Margin | 11.70% | -36.40% | +48.10 | HAE | /operating-margins <GO> |
| Net Profit Margin | 0.00% | -60.00% | +60.00 | HAE | /net-margins <GO> |
| Revenue Growth (YoY) | -2.00% | 39.90% | -41.90 | HTFL | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 3.89 | 26.00 | -22.11 | HTFL | /balance-sheet <GO> |
| Piotroski F-Score Quality | 7/9 | 5/9 | +2.00 | HAE | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 63.6 | 69.9 | -6.30 | HTFL | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | 1.00 | 0.90 | +0.10 | HAE | /macro-sensitivity <GO> |
| Forward P/E Multiple | — | 27.0x | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $5.45B | $5.26B | $186.8M | HAE | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | HAE REV | HTFL REV | HAE GROSS % | HTFL GROSS % | HAE FCF | HTFL FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $1.33B | $176.0M | 59.0% | 76.8% | $260.4M | -$59.0M |
| FY 2024 | $1.36B | $125.8M | 55.0% | 75.1% | $142.4M | -$73.4M |
| FY 2023 | $1.31B | $87.2M | — | — | $122.8M | -$80.4M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
HAE // BETA 1.00
HTFL // BETA 0.90